Inari Medical (NARI) Competitors $56.16 -0.59 (-1.04%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NARI vs. SOLV, SNN, PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVCR, and NVSTShould you be buying Inari Medical stock or one of its competitors? The main competitors of Inari Medical include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), and Envista (NVST). These companies are all part of the "medical equipment" industry. Inari Medical vs. Solventum Smith & Nephew Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics NovoCure Envista Solventum (NYSE:SOLV) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk. Does the MarketBeat Community favor SOLV or NARI? Inari Medical received 65 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 62.26% of users gave Inari Medical an outperform vote while only 5.56% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.56%Underperform Votes1794.44% Inari MedicalOutperform Votes6662.26% Underperform Votes4037.74% Do analysts prefer SOLV or NARI? Solventum currently has a consensus target price of $68.29, indicating a potential downside of 0.46%. Inari Medical has a consensus target price of $60.50, indicating a potential upside of 7.73%. Given Inari Medical's stronger consensus rating and higher possible upside, analysts plainly believe Inari Medical is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Inari Medical 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals have more ownership in SOLV or NARI? 91.0% of Inari Medical shares are held by institutional investors. 10.6% of Inari Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer SOLV or NARI? In the previous week, Solventum had 2 more articles in the media than Inari Medical. MarketBeat recorded 14 mentions for Solventum and 12 mentions for Inari Medical. Solventum's average media sentiment score of 1.29 beat Inari Medical's score of 0.63 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 10 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inari Medical 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SOLV or NARI more profitable? Solventum has a net margin of 0.00% compared to Inari Medical's net margin of -13.68%. Solventum's return on equity of 0.00% beat Inari Medical's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Inari Medical -13.68%-10.09%-6.60% Which has preferable earnings and valuation, SOLV or NARI? Solventum has higher revenue and earnings than Inari Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.26B1.43N/AN/AN/AInari Medical$574.50M5.72-$1.64M-$1.35-41.60 SummaryInari Medical beats Solventum on 8 of the 14 factors compared between the two stocks. Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get Inari Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NARI vs. The Competition Export to ExcelMetricInari MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.32B$4.41B$5.17B$9.32BDividend YieldN/A44.87%4.78%4.06%P/E Ratio-41.6025.33127.7717.55Price / Sales5.7246.521,261.39139.05Price / Cash660.1744.2041.0437.95Price / Book6.967.254.894.92Net Income-$1.64M$13.83M$119.40M$225.78M7 Day Performance2.02%-2.81%14.54%-1.47%1 Month Performance11.08%3.10%17.43%5.36%1 Year Performance-13.51%45.60%35.31%22.71% Inari Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NARIInari Medical2.5692 of 5 stars$56.16-1.0%$60.50+7.7%-13.5%$3.32B$574.50M-41.601,300Analyst ForecastNews CoverageSOLVSolventum1.42 of 5 stars$69.77+0.3%$68.29-2.1%N/A$12.05BN/A0.0022,000Positive NewsSNNSmith & Nephew3.8269 of 5 stars$25.51-0.1%N/A-3.8%$11.15B$5.55B13.0318,452News CoveragePENPenumbra4.1953 of 5 stars$247.93+1.0%$252.42+1.8%+0.8%$9.52B$1.16B285.524,200Analyst ForecastGKOSGlaukos4.0782 of 5 stars$143.57+3.3%$143.17-0.3%+79.6%$7.92B$360.35M-46.00780Short Interest ↓BLCOBausch + Lomb2.2616 of 5 stars$18.53-0.4%$20.58+11.1%+24.3%$6.53B$4.68B-17.7113,300Short Interest ↑INSPInspire Medical Systems4.6937 of 5 stars$188.59+0.4%$233.58+23.9%+1.4%$5.65B$755.59M176.781,011Short Interest ↓Positive NewsPRCTPROCEPT BioRobotics3.0552 of 5 stars$89.81+0.6%$97.86+9.0%+104.0%$4.69B$136.19M0.00626Positive NewsAXNXAxonics1.1641 of 5 stars$70.98+0.8%$71.00+0.0%+21.8%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.87 of 5 stars$32.71-2.1%$32.67-0.1%+136.7%$3.54B$577.74M-23.861,453NVSTEnvista3.621 of 5 stars$19.55+0.4%$20.65+5.6%-19.3%$3.36B$2.50B-2.5112,800Positive News Related Companies and Tools Related Companies Solventum Competitors Smith & Nephew Competitors Penumbra Competitors Glaukos Competitors Bausch + Lomb Competitors Inspire Medical Systems Competitors PROCEPT BioRobotics Competitors Axonics Competitors NovoCure Competitors Envista Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NARI) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NARI Stock Alerts